Inhalation anaesthesia refers to chemical compounds that have general anaesthetic properties and are administered to a patient via inhalation. The global Inhalation anaesthesia market is expected to rise with a CAGR of over 3.5% over forecast period of 2019-2026. Anaesthesia as defined by the Food and Drug Administration (FDA, US) refers to reversible state of unconsciousness resulting in lack of pain and muscle relaxation important for performing surgical procedures. The major driver for the growth of global Inhalation anaesthesia market is the growing prevalence of chronic diseases such as cancer, cardiovascular, etc. that in turn has increased the adoption of inhalation anaesthesia due to increased number of surgical procedures. according to Our World in Data. About 42 million people worldwide had cancer in 2016, a two-fold increase from 1990 when approximately 19 million had cancer. In addition, breast cancer has been identified as the leading type of cancer, with eight million diagnoses in 2016.
North America holds the largest market share in terms of revenue in 2018. North America Inhalation anaesthesia market is primarily driven by sound healthcare infrastructure in the region, coupled with growing prevalence of chronic disease, growing number of cosmetic procedures (Surgical and non-surgical) and rising healthcare expenditure. According to National Centre for Biotechnology Information (NCBI) USA, on an average, 30 million anaesthetics are administered in USA every year. Increasing number of surgeries of elderly population is likely to supplement demand for Inhalation anaesthesia. The National Survey Ambulatory Surgery USA, in 2016 anticipated that the number of surgeries performed on geriatric population is likely to increase by 12% per annum (YoY) in the US alone. These factors are likely to supplement huge growth opportunity in the North America Inhalation anaesthesia market. However, Asia pacific Inhalation anaesthesia market is expected to grow at the highest rate over the forecast period owing to increasing number of hospitals, clinics in the region coupled with rising geriatric population and increasing healthcare expenditure. Furthermore, increasing medical tourism in Japan, China and India for the cost-effective treatment is also expected to lead the market growth in the region.
The global Inhalation anaesthesia market report covers segmentation analysis of products and outlook. The platform segment is further segmented into Sevoflurane, Desflurane, Isoflurane. Sevoflurane is expected to dominate the product segment primarily due to benefits associated with sevoflurane that include low flammability, nominal respiratory and cardiovascular side effects, non-pungent odour, intrinsic stability and others. These benefits of sevoflurane have leveraged huge adoption of sevoflurane for inhalation anaesthesia. Further Desflurane market is expected to gain traction over the forecast period as the use of desflurane allows easy and quick recovery in comparison to sevoflurane. These benefits of Desflurane is expected to inject huge growth opportunity in the global Inhalation anaesthesia market.
The major market players of the global Inhalation anaesthesia market are: Lunan Pharmaceuticals (China), Anesthesia Gas Reclamation, Baxter International (US), Piramal healthcare (India) and Others. All such companies are accepting numerous tactics such as merger & acquisition, collaboration, partnership and product launch. Whereas, Merger and acquisition is the key strategies adopted by the companies in the Inhalation anaesthesia market. For instance, in 2017 Baxter International (US) acquired Claris Injectables (US), with the acquisition Baxter International has gained access to whole product portfolio of Claris Injectables. The acquisition would help to expand product breath of the company and gain more revenue.
1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Inhalation Anaesthesia Market
2.1.1. Global Inhalation Anaesthesia Market, by Product, 2018 (US$ Mn)
2.1.2. Global Inhalation Anaesthesia Market, by Outlook, 2018 (US$ Mn)
2.1.3. Global Inhalation Anaesthesia Market, by Level of Automation, 2018 (US$ Mn)
2.1.4. Global Inhalation Anaesthesia Market, by Geography, 2018 (US$ Mn)
3. Market Dynamics
3.1. Introduction
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Growing Geriatric Population
3.2.1.2. Increasing Prevalence of Chronic Diseases Globally
3.2.1.3. Escalating Number of Emergency Cases And Accident
3.2.1.4. Reduction in The Recovery Time Subsequently Surgery
3.2.2. Market Restraints
3.2.2.1. Side Effects Associated with Anaesthesia
3.2.2.2. Low Availability of Skilled Anesthetics Experts
3.2.3. Market Opportunities
3.2.3.1. Increasing Number of Cosmetic Surgeries
3.2.3.2. Growing Healthcare Expenditure
3.2.4. Market Challenges
3.2.4.1. Environmental Concerns Associated with Anaesthesia Gas
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market share of Key Players, 2018
3.5. Top five findings and strategic analysis
4. Global Inhalation Anaesthesia Market, by Product
4.1. Overview
4.1.1. Global Inhalation Anaesthesia Market Value Share, by Product, 2018 & 2026 (Value, %)
4.1.2. Global Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
4.2. Desflurane
4.2.1. Global Inhalation Anaesthesia Market for Desflurane, 2019-2026 (US$ Mn)
4.2.2. Global Inhalation Anaesthesia Market for Desflurane, by Region 2019-2026 (US$ Mn)
4.3. Sevoflurane
4.3.1. Global Inhalation Anaesthesia Market for Sevoflurane, 2019-2026 (US$ Mn)
4.3.2. Global Inhalation Anaesthesia Market for Sevoflurane, by Region 2019-2026 (US$ Mn)
4.4. Isoflurane
4.4.1. Global Inhalation Anaesthesia Market for Isoflurane, 2019-2026 (US$ Mn)
4.4.2. Global Inhalation Anaesthesia Market for Isoflurane, by Region 2019-2026 (US$ Mn)
5. Global Inhalation Anaesthesia Market, by Outlook
5.1. Overview
5.1.1. Global Inhalation Anaesthesia Market Value Share, by Outlook, 2018 & 2026 (Value, %)
5.1.2. Global Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
5.2. Induction Anaesthesia
5.2.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.2.2. Global Inhalation Anaesthesia Market for Induction Anaesthesia, 2019-2026 (US$ Mn)
5.2.3. Global Inhalation Anaesthesia Market for Induction Anaesthesia, by Region 2019-2026 (US$ Mn)
5.3. Maintenance Anaesthesia
5.3.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.3.2. Global Inhalation Anaesthesia Market for Maintenance Anaesthesia, 2019-2026 (US$ Mn)
5.3.3. Global Inhalation Anaesthesia Market for Maintenance Anaesthesia, by Region 2019-2026 (US$ Mn)
6. North America Inhalation Anaesthesia Market Analysis
6.1. Overview
6.1.1. North America Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
6.1.2. North America Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
6.1.3. North America Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
6.1.4. North America Inhalation Anaesthesia Market, by Country, 2019-2026 (US$ Mn)
6.1.4.1. United States
6.1.4.1.1. United States Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7. Europe Inhalation Anaesthesia Market Analysis
7.1. Overview
7.1.1. Europe Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
7.1.2. Europe Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
7.1.3. Europe Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
7.1.4. Europe Inhalation Anaesthesia Market, by Country/Region, 2019-2026 (US$ Mn)
7.1.4.1. UK
7.1.4.1.1. UK Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7.1.4.2. Germany
7.1.4.2.1. Germany Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7.1.4.3. France
7.1.4.3.1. France Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7.1.4.4. Rest of Europe
7.1.4.4.1. Rest of Europe Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8. Asia Pacific Inhalation Anaesthesia Market Analysis
8.1. Overview
8.1.1. Asia Pacific Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
8.1.2. Asia Pacific Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
8.1.3. Asia Pacific Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
8.1.4. Asia Pacific Inhalation Anaesthesia Market, by Country/Region, 2019-2026 (US$ Mn)
8.1.4.1. China
8.1.4.1.1. China Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8.1.4.2. India
8.1.4.2.1. India Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8.1.4.3. Japan
8.1.4.3.1. Japan Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8.1.4.4. Rest of Asia Pacific
8.1.4.4.1. Rest of Asia Pacific Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
9. Rest of the World Inhalation Anaesthesia Market Analysis
9.1. Overview
9.1.1. Rest of the World Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
9.1.2. Rest of the World Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
9.1.3. Rest of the World Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
9.1.4. Rest of the World Inhalation Anaesthesia Market, by Country/Region, 2019 – 2026 (US$ Mn)
9.1.4.1. Latin America
9.1.4.1.1. Latin America Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
9.1.4.2. MENA
9.1.4.2.1. MENA Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
10. Company Profiles
10.1. Abbvie/Abbott
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. Key Strategies
10.1.4. Key Conclusion
10.2. Baxter Healthcare
10.2.1. Company Overview
10.2.2. Product Portfolio
10.2.3. Key Strategies
10.2.4. Key Conclusion
10.3. Eisai Co., Ltd
10.3.1. Company Overview
10.3.2. Product Portfolio
10.3.3. Key Strategies
10.3.4. Key Conclusion
10.4. Piramal Healthcare
10.4.1. Company Overview
10.4.2. Product Portfolio
10.4.3. Key Strategies
10.4.4. Key Conclusion
10.5. Halocarbon Products
10.5.1. Company Overview
10.5.2. Product Portfolio
10.5.3. Key Strategies
10.5.4. Key Conclusion
10.6. Hikma
10.6.1. Company Overview
10.6.2. Product Portfolio
10.6.3. Key Strategies
10.6.4. Key Conclusion
10.7. Lunan Pharmaceuticals
10.7.1. Company Overview
10.7.2. Product Portfolio
10.7.3. Key Strategies
10.7.4. Key Conclusion
10.8. Mylan Inc.
10.8.1. Company Overview
10.8.2. Product Portfolio
10.8.3. Key Strategies
10.8.4. Key Conclusion
10.9. Richter Pharma
10.9.1. Company Overview
10.9.2. Product Portfolio
10.9.3. Key Strategies
10.9.4. Key Conclusion
10.10. Par Pharmaceutical Companies.
10.10.1. Company Overview
10.10.2. Product Portfolio
10.10.3. Key Strategies
10.10.4. Key Conclusion
1. Global Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
2. Global Inhalation Anaesthesia Market for Desflurane, by Region 2019-2026 (US$ Mn)
3. Global Inhalation Anaesthesia Market for Sevoflurane, by Region 2019-2026 (US$ Mn)
4. Global Inhalation Anaesthesia Market for Isoflurane, by Region 2019-2026 (US$ Mn).
5. Global Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
6. Global Inhalation Anaesthesia Market for Induction Anaesthesia, by Region 2019-2026 (US$ Mn)
7. Global Inhalation Anaesthesia Market for Maintenance Anaesthesia, by Region 2019-2026 (US$ Mn)
8. Global Inhalation Anaesthesia Market, by Geography, 2019-2026 (US$ Mn)
9. North America Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
10. North America Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
11. North America Inhalation Anaesthesia Market, by Country, 2019-2026 (US$ Mn)
12. Europe Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
13. Europe Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
14. Europe Inhalation Anaesthesia Market, by Country/Region, 2019-2026 (US$ Mn)
15. Asia Pacific Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
16. Asia Pacific Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
17. Asia Pacific Inhalation Anaesthesia Market, by Country/Region, 2019-2026 (US$ Mn)
18. Rest of the World Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
19. Rest of the World Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
20. Rest of the World Inhalation Anaesthesia Market, by Country/Region, 2019 – 2026 (US$ Mn)
1. Global Inhalation Anaesthesia Market, by Product, 2018 (US$ Mn)
2. Global Inhalation Anaesthesia Market, by Outlook, 2018 (US$ Mn)
3. Global Inhalation Anaesthesia Market, by Geography, 2018 (US$ Mn)
4. Global Inhalation Anaesthesia Market Value Share, by Product, 2018 & 2026 (Value, %)
5. Global Inhalation Anaesthesia Market for Desflurane, 2019-2026 (US$ Mn)
6. Global Inhalation Anaesthesia Market for Sevoflurane, 2019-2026 (US$ Mn)
7. Global Inhalation Anaesthesia Market for Isoflurane, 2019-2026 (US$ Mn)
8. Global Inhalation Anaesthesia Market Value Share, by Outlook, 2018 & 2026 (Value, %)
9. Global Inhalation Anaesthesia Market for Induction Anaesthesia, 2019-2026 (US$ Mn)
10. Global Inhalation Anaesthesia Market for Maintenance Anaesthesia, 2019-2026 (US$ Mn)
11. United States Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
12. Canada Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
13. UK Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
14. Germany Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
15. France Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
16. Rest of Europe Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
17. China Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
18. India Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
19. Japan Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
20. Rest of Asia Pacific Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
21. Latin America Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
22. MENA Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)